Tumor hypoxia is associated with tumor progression and resistance to various treatments.
Noninvasive imaging using positron emission tomography (PET) and F-18-labeled …

For several decades, cytotoxic chemotherapeutic agents were considered the basis of
anticancer treatment for patients with metastatic tumors. A decrease in tumor burden …

Objective: To develop decision trees predicting for tumor volume reduction in patients with
head and neck (H&N) cancer using pretreatment clinical and pathological parameters …

Tumor hypoxia is a clinically relevant cause of radiation resistance. Direct measurements of
tumor oxygenation have been performed predominantly with the Eppendorf histograph and …

Purpose The purpose of this study was to prospectively investigate reoxygenation in the
early phase of fractionated radiotherapy and serial changes of tumoricidal effects associated …

Positron emission tomography-computed tomography (PET-CT) has changed cancer
imaging in the last decade, for better. It can be employed for radiation treatment planning of …

Purpose The aim of this pilot study was to explore simultaneous functional PET/MR for
biological characterization of tumors and potential future treatment adaptations. To …

Single-dose preoperative stereotactic body radiotherapy is a novel radiotherapy technique
for the early-stage breast cancer, and the treatment response pattern of this technique needs …

Purpose PET hypoxia imaging of head and neck cancer (HNC) has the potential to stratify
the response to radiochemotherapy. The aim of this work was to quantify the statistical …

Tumour hypoxia is a well-known negative prognostic marker in almost all solid tumours.[18F]
Fluoromisonidazole (FMISO)-positron emission tomography (PET) is a non-invasive method …